BRPI0402854A - treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds - Google Patents

treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds

Info

Publication number
BRPI0402854A
BRPI0402854A BRPI0402854A BRPI0402854A BR PI0402854 A BRPI0402854 A BR PI0402854A BR PI0402854 A BRPI0402854 A BR PI0402854A BR PI0402854 A BRPI0402854 A BR PI0402854A
Authority
BR
Brazil
Prior art keywords
melanoma
study
treatment
mesoic
thiadiazole compounds
Prior art date
Application number
Other languages
Portuguese (pt)
Inventor
Maria Benigna Martine Oliveira
Andrea Senff Ribeiro
Silvio Sanches Veiga
Aurea Echevarria
Edson Fernandes Da Silva
Original Assignee
Univ Fed Do Parana
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Fed Do Parana filed Critical Univ Fed Do Parana
Priority to BRPI0402854 priority Critical patent/BRPI0402854A/en
Publication of BRPI0402854A publication Critical patent/BRPI0402854A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"TRATAMENTO E ESTUDO DO MELANOMA COM A UTILIZAçãO DOS COMPOSTOS 1,3,4-TIADIAZóIS MESOIÈNICOS". Patente de invenção para compostos 1,3,4-tiadiazóis mesoiónicos utilizados no como agentes antineoplásicos, caracterizada por sua ação contra o melanoma independente da dose, via ou modo de utilização."TREATMENT AND STUDY OF MELANOMA WITH THE USE OF MESOIENIC 1,3,4-TIADIAZOLE COMPOUNDS". Patent for mesoionic 1,3,4-thiadiazole compounds used as antineoplastic agents, characterized by their action against melanoma regardless of dose, route or mode of use.

BRPI0402854 2004-07-01 2004-07-01 treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds BRPI0402854A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0402854 BRPI0402854A (en) 2004-07-01 2004-07-01 treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
BRPI0402854 BRPI0402854A (en) 2004-07-01 2004-07-01 treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds

Publications (1)

Publication Number Publication Date
BRPI0402854A true BRPI0402854A (en) 2006-02-14

Family

ID=36037101

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0402854 BRPI0402854A (en) 2004-07-01 2004-07-01 treatment and study of melanoma using mesoic 1,3,4-thiadiazole compounds

Country Status (1)

Country Link
BR (1) BRPI0402854A (en)

Similar Documents

Publication Publication Date Title
BR0313676A (en) Pyrimidine derivatives and their use as cb2 modulators
BRPI0509140A (en) processes for treating hiv infection
EA200701845A1 (en) ROFLUMILAST FOR TREATMENT OF DIABETES MELLITUS
SV2002000245A (en) SUBSTITUTED OXAZOLIDINONES AND ITS USE REF. READ 34122-SV
ECSP034774A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
ECSP034773A (en) PIRAZOLOPIRIMMIDINAS AS THERAPEUTIC AGENTS
CY1109732T1 (en) USE OF PRODUCERS OF VENZO-CONNECTED SULFAMIDI EQUIPMENT FOR TREATMENT PAIN
BRPI0407897A (en) cyanopyridine derivatives useful in the treatment of cancer and other disorders
BR0015992A (en) Compounds, their use, and therapeutic associations
DE50310516D1 (en) Fredericamycin DERIVATIVES
BR0312573A (en) Phenyl- [4- (3-phenyl-1h-pyrazol-4-yl) -pyrimidin-2-yl] -amine derivatives
EA200601837A1 (en) PETROXASES FOR TREATMENT OF RESPIRATORY DISEASES
DE502004002571D1 (en) SUBSTITUTED 3-PYRROLIDIN INDOL DERIVATIVES
SE0401342D0 (en) Therapeutic compounds
DE602005010744D1 (en) PIPERAZINYLPYRIDINE DERIVATIVES AS AGENTS AGAINST ADIPOSITAS
IL178727A (en) Tetrahydropyridothiophene derivatives and pharmaceutical compositions containing the same
CY1110130T1 (en) MORPHOLINE PRODUCTS FOR USE AS DOPAMINE AGONISTS IN THERAPEUTIC DISEASE Therapeutic Treatment I.A.
BR0313385A (en) Pyrimidine-2,4-dione derivatives as matrix metalloproteinase inhibitors
BRPI0409359A (en) somatostatin-dopamine chimeric analogs
BRPI0417858A (en) compound, pharmaceutical composition, and use of a pharmaceutical composition
NO20063619L (en) Diarylmethylpiperazine derivatives, preparation and use thereof
SE0102147D0 (en) New methods
CY1105317T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
CY1105142T1 (en) USE OF 6-DIMETHYLAMINOMETHYL-1-PHENYL-CYCLOHEXANE SUBSTITUTED COMPOUNDS FOR THE TREATMENT OF URINARY INCONTINENCE
EA200501528A1 (en) APPLICATION OF CLUSTERIN FOR THE TREATMENT AND / OR PREVENTION OF PERIPHERAL NEUROLOGICAL DISEASES

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE A 5A ANUIDADE.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2160 DE 29/05/2012.

B08H Application fees: decision cancelled

Free format text: REFERENTE A DESPACHOS 8.6 E 8.11 NAS RPIS 2160 E 2180 DE 29/05/2012 E 16/10/2012, RESPECTIVAMENTE.

B07D Technical examination (opinion) related to article 229 of industrial property law
B06F Objections, documents and/or translations needed after an examination request according art. 34 industrial property law
B07E Notice of approval relating to section 229 industrial property law

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Technical examination (opinion): publication of technical examination (opinion)
B09B Decision: refusal